[EXEL has advanced and long pipelines ranged
from cancer to various metabolic and cardiovascular disorders. It has
multiple collaborators like Bristol-Myers Squibb Company; Genentech, Inc.;
GlaxoSmithKline; Wyeth Pharmaceuticals; and Daiichi-Sankyo plus today's new
partiner Boehringer Ingelheim. http://www.exelixis.com/pipeline.shtml